Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crown Crafts | CRWS | Jan 23, 2025 | 4.49 | +0.22 |
Crown ElectroKinetics | CRKN | Jan 23, 2025 | 0.10 | -7.33 |
Crown Holdings | CCK | Jan 23, 2025 | 88.42 | +1.66 |
Crown LNG | CGBS | Jan 23, 2025 | 0.68 | -2.98 |
Cryo-Cell International | CCEL | Jan 23, 2025 | 7.61 | +1.87 |
CryoPort | CYRX | Jan 23, 2025 | 8.32 | -2.92 |
CS Disco | LAW | Jan 23, 2025 | 4.97 | +0.40 |
CSG Systems International | CSGS | Jan 23, 2025 | 54.98 | +1.70 |
CSP | CSPI | Jan 23, 2025 | 16.91 | -1.34 |
CSW Industrials | CSWI | Jan 23, 2025 | 380.99 | -2.05 |
CSX | CSX | Jan 23, 2025 | 33.67 | +1.29 |
CTO Realty Growth | CTO | Jan 23, 2025 | 19.29 | +0.26 |
CTO Realty Growth A Pref | CTO-A | Jan 23, 2025 | 22.12 | -1.21 |
CTS | CTS | Jan 23, 2025 | 51.54 | -2.66 |
CubeSmart | CUBE | Jan 23, 2025 | 41.12 | +1.01 |
Cue Biopharma | CUE | Jan 23, 2025 | 1.39 | +14.88 |
Cullen Frost Bankers B Pref | CFR-B | Jan 23, 2025 | 18.30 | -0.16 |
Cullen/Frost Bankers | CFR | Jan 23, 2025 | 140.22 | +0.02 |
Cullinan Therapeutics | CGEM | Jan 23, 2025 | 10.56 | +0.48 |
Culp | CULP | Jan 23, 2025 | 5.43 | +1.12 |
Cumberland Pharmaceuticals | CPIX | Jan 23, 2025 | 2.50 | -4.58 |
Cummins | CMI | Jan 23, 2025 | 368.91 | +0.80 |
Cumulus Media A | CMLS | Jan 23, 2025 | 0.88 | +16.73 |
Curbline Properties | CURB | Jan 23, 2025 | 23.71 | +0.72 |
Curevac N.V. | CVAC | Jan 23, 2025 | 3.96 | 0.00 |
CuriosityStream | CURI | Jan 23, 2025 | 2.19 | +0.46 |
Curis | CRIS | Jan 23, 2025 | 3.43 | +4.89 |
CURRENC Group | CURR | Jan 23, 2025 | 1.90 | -7.32 |
Curtiss-Wright | CW | Jan 23, 2025 | 384.07 | +0.40 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Jan 23, 2025 | 48.88 | -1.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.